Galectin 8 polyclonal, anti-human, mouse, rat

Background:
Several proteins have been identified as specific markers of prostate cancer, and they may be useful as diagnostic indicators. PSA, prostate specific antigen, is the classical indicator for transformed prostate tissue, however, in addition to being up-regulated in prostate cancer, PSA is also up-regulated in non-malignant conditions, such as benign prostatic hyperplasia prostate. Galectin-8, also known as prostate-specific membrane antigen (PCTA-1), is an additional prostate-specific antigen that is overexpressed only in malignant tumors and therefore is a more specific identifier of malignancies. It is a member of the galectin gene family which mediates bothe cell-cell and cell-matrix interactions in a manner similar to the selectin subgroup of C-type lectins.

Alternative Name:
Gal-8, Po66-CBP, PCTA-1, LGALS8, Gal 8, Gal-8, Gal8, Galectin-8, galectin-8g, Lectin galactoside binding soluble 8, LEG8, LGAL S8, Lgals8, PCTA 1, PCTA-1, PCTA1, Po66 carbohydrate binding protein, Po66 carbohydrate-binding protein, Po66 CBP, Po66-CBP, Prostate carcinoma tumor antigen 1,

Application Dilution:
WB:1:500-1:1,000
ICC/IF:1:400-1:800
IHC:1:50-1:200
FC:1:50-1:100

Specificity: Galectin 8 polyclonal antibody detects endogenous levels of Galectin 8 protein.

Immunogen:
Recombinant protein

MW: 40 kDa

Swiss-Prot: O00214(Human)

Purification & Purity:
ProA affinity purified

Format:
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Storage:
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

For research use only, not for use in diagnostic procedure.